Journal article
Engineering Intrinsically Zirconium‐89 Radiolabeled Self‐Destructing Mesoporous Silica Nanostructures for In Vivo Biodistribution and Tumor Targeting Studies
Advanced science, Vol.3(11), pp.1600122-n/a
11/2016
DOI: 10.1002/advs.201600122
PMCID: PMC5102673
PMID: 27980987
Abstract
A systematic study of in vitro and in vivo behavior of biodegradable mesoporous silica nanoparticles (bMSNs), designed to carry multiple cargos (both small and macromolecular drugs) and subsequently self‐destruct following release of their payloads, is presented. Complete degradation of bMSNs is seen within 21 d of incubation in simulated body fluid. The as‐synthesized bMSNs are intrinsically radiolabeled with oxophilic zirconium‐89 (
89
Zr,
t
1/2
= 78.4 h) radionuclide to track their in vivo pharmacokinetics via positron emission tomography imaging. Rapid and persistent CD105 specific tumor vasculature targeting is successfully demonstrated in murine model of metastatic breast cancer by using TRC105 (an anti‐CD105 antibody)‐conjugated bMSNs. This study serves to illustrate a simple, versatile, and readily tunable approach to potentially overcome the current challenges facing nanomedicine and further the goals of personalized nanotheranostics.
Details
- Title: Subtitle
- Engineering Intrinsically Zirconium‐89 Radiolabeled Self‐Destructing Mesoporous Silica Nanostructures for In Vivo Biodistribution and Tumor Targeting Studies
- Creators
- Shreya Goel - University of Wisconsin–MadisonFeng Chen - University of Wisconsin–MadisonShijie Luan - Temple UniversityHector F. Valdovinos - University of Wisconsin–MadisonSixiang Shi - University of Wisconsin–MadisonStephen A. Graves - University of Wisconsin–MadisonFanrong Ai - University of Wisconsin–MadisonTodd E. Barnhart - University of Wisconsin–MadisonCharles P. Theuer - Tracon Pharmaceuticals (United States)Weibo Cai - University of Wisconsin–Madison
- Resource Type
- Journal article
- Publication Details
- Advanced science, Vol.3(11), pp.1600122-n/a
- DOI
- 10.1002/advs.201600122
- PMID
- 27980987
- PMCID
- PMC5102673
- NLM abbreviation
- Adv Sci (Weinh)
- ISSN
- 2198-3844
- eISSN
- 2198-3844
- Publisher
- John Wiley and Sons Inc
- Language
- English
- Date published
- 11/2016
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Radiology; Radiation Oncology
- Record Identifier
- 9984383899502771
Metrics
12 Record Views